Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 691491, 9 pages
http://dx.doi.org/10.1155/2015/691491
Research Article

Role of the RAGE Axis during the Immune Response after Severe Trauma: A Prospective Pilot Study

1Department of Anesthesiology, Heidelberg University Hospital, 69120 Heidelberg, Germany
2Department of Medicine I and Clinical Chemistry, Heidelberg University Hospital, 69120 Heidelberg, Germany
3Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University, 35392 Giessen, Germany
4Department of General and Thoracic Surgery, Justus-Liebig-University, 35392 Giessen, Germany
5Department of Trauma, Hand and Reconstructive Surgery, University Hospital of Giessen-Marburg GmbH, Campus Giessen, 35392 Giessen, Germany

Received 6 October 2015; Revised 24 November 2015; Accepted 9 December 2015

Academic Editor: Marc Pouliot

Copyright © 2015 Florian Uhle et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. L. Murray and A. D. Lopez, “Alternative projections of mortality and disability by cause 1990–2020: global Burden of Disease study,” The Lancet, vol. 349, no. 9064, pp. 1498–1504, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. E. G. Krug, G. K. Sharma, and R. Lozano, “The global burden of injuries,” American Journal of Public Health, vol. 90, no. 4, pp. 523–526, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. H. E. Campbell, E. A. Stokes, D. N. Bargo et al., “Quantifying the healthcare costs of treating severely bleeding major trauma patients: a national study for England,” Critical Care, vol. 19, article 276, 2015. View at Publisher · View at Google Scholar
  4. M. Keel and O. Trentz, “Pathophysiology of polytrauma,” Injury, vol. 36, no. 6, pp. 691–709, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Levi and T. van der Poll, “Inflammation and coagulation,” Critical Care Medicine, vol. 38, no. 2, supplement, pp. S26–S34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. E. Bianchi, “DAMPs, PAMPs and alarmins: all we need to know about danger,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 1–5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Kislinger, C. Fu, B. Huber et al., “Nε-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression,” The Journal of Biological Chemistry, vol. 274, no. 44, pp. 31740–31749, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Xue, V. Rai, D. Singer et al., “Advanced glycation end product recognition by the receptor for AGEs,” Structure, vol. 19, no. 5, pp. 722–732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. K. Chuah, R. Basir, H. Talib, T. H. Tie, and N. Nordin, “Receptor for advanced glycation end products and its involvement in inflammatory diseases,” International Journal of Inflammation, vol. 2013, Article ID 403460, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager, “Advanced glycation end products: sparking the development of diabetic vascular injury,” Circulation, vol. 114, no. 6, pp. 597–605, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. V. P. Singh, A. Bali, N. Singh, and A. S. Jaggi, “Advanced glycation end products and diabetic complications,” Korean Journal of Physiology and Pharmacology, vol. 18, no. 1, pp. 1–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. F. Yan, R. Ramasamy, and A. M. Schmidt, “Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging,” Biochemical Pharmacology, vol. 79, no. 10, pp. 1379–1386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Bopp, S. Hofer, J. Weitz et al., “sRAGE is elevated in septic patients and associated with patients outcome,” Journal of Surgical Research, vol. 147, no. 1, pp. 79–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Matsumoto, N. Matsumoto, H. Ogura et al., “The clinical significance of circulating soluble RAGE in patients with severe sepsis,” Journal of Trauma and Acute Care Surgery, vol. 78, no. 6, pp. 1086–1094, 2015. View at Publisher · View at Google Scholar
  15. F. Kimura, H. Shimizu, H. Yoshidome, M. Ohtsuka, and M. Miyazaki, “Immunosuppression following surgical and traumatic injury,” Surgery Today, vol. 40, no. 9, pp. 793–808, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Uhle, D. van den Nouland, S. Little et al., “Plasmatic isoforms of cytokeratin 18 and RAGE after severe trauma: a longitudinal cohort study,” Journal of Trauma and Acute Care Surgery, vol. 77, no. 4, pp. 577–584, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. Cohen, M. Carles, K. Brohi et al., “Early release of soluble receptor for advanced glycation endproducts after severe trauma in humans,” Journal of Trauma—Injury, Infection & Critical Care, vol. 68, no. 6, pp. 1273–1278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. J. Thornalley, A. Langborg, and H. S. Minhas, “Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose,” The Biochemical Journal, vol. 344, part 1, pp. 109–116, 1999. View at Google Scholar
  19. A. C. McLellan, S. A. Phillips, and P. J. Thornalley, “The assay of methylglyoxal in biological systems byderivatization with 1,2-diamino-4,5-dimethoxybenzene,” Analytical Biochemistry, vol. 206, no. 1, pp. 17–23, 1992. View at Publisher · View at Google Scholar
  20. L. Zeng, “Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma,” Critical Care, vol. 19, article 1, 7 pages, 2015. View at Publisher · View at Google Scholar
  21. S. T. Buckley and C. Ehrhardt, “The receptor for advanced glycation end products (RAGE) and the lung,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 917108, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. J. Weber, A. S. A. Gracon, M. S. Ripsch et al., “The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation,” Science Translational Medicine, vol. 6, no. 252, Article ID 252ra124, 2014. View at Publisher · View at Google Scholar
  23. C. Martin, C. Boisson, M. Haccoun, L. Thomachot, and J.-L. Mege, “Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma,” Critical Care Medicine, vol. 25, no. 11, pp. 1813–1819, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Cohen, K. Brohi, C. S. Calfee et al., “Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion,” Critical Care, vol. 13, article R174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. K. Aneja, A. Tsung, H. Sjodin et al., “Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance,” Journal of Leukocyte Biology, vol. 84, no. 5, pp. 1326–1334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Liesz, A. Dalpke, E. Mracsko et al., “DAMP signaling is a key pathway inducing immune modulation after brain injury,” The Journal of Neuroscience, vol. 35, no. 2, pp. 583–598, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Zhang, M. Raoof, Y. Chen et al., “Circulating mitochondrial DAMPs cause inflammatory responses to injury,” Nature, vol. 464, no. 7285, pp. 104–107, 2010. View at Publisher · View at Google Scholar
  28. A. Raucci, S. Cugusi, A. Antonelli et al., “A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10),” The FASEB Journal, vol. 22, no. 10, pp. 3716–3727, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Venet, S. Tissot, A.-L. Debard et al., “Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock,” Critical Care Medicine, vol. 35, no. 8, pp. 1910–1917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Foell, H. Wittkowski, C. Kessel et al., “Proinflammatory S100A12 can activate human monocytes via toll-like receptor 4,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 12, pp. 1324–1334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Austermann, J. Friesenhagen, S. Fassl et al., “Alarmins MRP8 and MRP14 induce stress tolerance in phagocytes under sterile inflammatory conditions,” Cell Reports, vol. 9, no. 6, pp. 2112–2124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. E. López-Collazo and C. del Fresno, “Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences,” Critical Care, vol. 17, no. 6, article 242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Ahmed, R. Babaei-Jadidi, S. K. Howell, P. J. Beisswenger, and P. J. Thornalley, “Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes,” Diabetologia, vol. 48, no. 8, pp. 1590–1603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Brenner, T. Fleming, F. Uhle et al., “Methylglyoxal as a new biomarker in patients with septic shock: an observational clinical study,” Critical Care, vol. 18, article 683, 2014. View at Publisher · View at Google Scholar
  36. A. Bierhaus, T. Fleming, S. Stoyanov et al., “Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy,” Nature Medicine, vol. 18, no. 6, pp. 926–933, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. I. M. Chiu, B. A. Heesters, N. Ghasemlou et al., “Bacteria activate sensory neurons that modulate pain and inflammation,” Nature, vol. 501, no. 7465, pp. 52–57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Deane, I. Singh, A. P. Sagare et al., “A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease,” The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1377–1392, 2012. View at Publisher · View at Google Scholar · View at Scopus